Hikal Ltd.
Fundamentals
- Market cap
- ₹2,650 cr
- ROE
- 7.19%
- Debt / equity
- 0.60
- Div yield
- 0.28%
- 52-week range
- 146.25 — 372.70
Company snapshot
Hikal Ltd.
CDMO
₹2,649 cr
Latest quarter · Mar 2026
Sales₹519 cr
Net profit₹14 cr
Op. margin+20.3%
EPS₹1.17
Strength & growth
Debt / equity0.60×
Current ratio1.20×
Sales CAGR+6.3%
EPS CAGR−10.2%
The timeline — 5 notes on Hikal Ltd.
May 2026
- 27 May 26 · 5:05 PM IST Brief Brief · Earnings · Small cap
Hikal's earnings release adds no new data to prior disclosures.
The company's latest press release provides qualitative commentary on its FY26 performance but contains no material financial information beyond what was already filed.
- 27 May 26 · 5:00 PM IST Brief Brief · Earnings · Small cap
Hikal's latest investor presentation adds no new information
The company released a routine investor presentation for Q4 and FY26, but the document contains no material data beyond the previously disclosed earnings.
- 27 May 26 · 4:16 PM IST Brief Brief · Small cap
Hikal fills key division vacancy and closes internal probe
Ravi Khadabadi takes over the Crop Protection & Specialty Chemicals unit, while an investigation into employee irregularities concludes with no financial impact.
- 27 May 26 · 4:07 PM IST Brief Brief · Earnings · Small cap
Hikal swings to a loss as USFDA issues and impairments bite
The company reported a net loss of ₹487 million for FY26, down from a profit of ₹909 million, while slashing its dividend payout by more than half.